Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Shares withheld for taxes SVP, CFO & Treasurer gave up 22,235 shares (to pay taxes)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Exercise or conversion CEO and President acquired 100,000 shares (option exercise)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award SVP, Chief Medical Officer acquired 29,400 shares (grant or award)
  13. 4 Grant or award SVP, Chief Business Officer acquired 19,400 shares (grant or award)
  14. 4 Grant or award SVP, General Counsel, Sec. acquired 17,500 shares (grant or award)
  15. 4 Grant or award CEO and President acquired 88,900 shares (grant or award)
  16. 4 Grant or award SVP, CFO & Treasurer acquired 19,500 shares (grant or award)
  17. 4 Grant or award SVP, Chief Development Officer acquired 17,500 shares (grant or award)
  18. 4 Open-market sale Director sold 1,000 shares at $14.62 ($14,620)
  19. 4 Open-market sale Director sold 1,188 shares at $19.64 ($23,332)
  20. 4 Open-market sale SVP, General Counsel, Sec. sold 7,803 shares at an average $19.89 ($155,188)

Page 12 of 19 · 378 filings